Ken Griffin Harpoon Therapeutics, Inc. Put Options Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$0.55 - $0.82 $605 - $902
-1,100 Reduced 8.33%
12,100 $8,000
Q1 2023

May 15, 2023
BUY
$0.65 - $1.37 $2,925 - $6,165
4,500 Added 51.72%
13,200 $9,000
Q4 2022

Feb 14, 2023
BUY
$0.6 - $1.41 $5,220 - $12,267
8,700 New
8,700 $6,000

Others Institutions Holding HARP

# of Institutions
2
Shares Held
353K
Call Options Held
0
Put Options Held
0
View Full List

About Harpoon Therapeutics, Inc.

HARP Quotes by TradingView
  • Ticker HARP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,106,800
  • Description
  • Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...
More about HARP
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email